Revance Therapeutics Inc (NASDAQ:RVNC)

31.71
Delayed Data
As of Mar 24
 +0.26 / +0.83%
Today’s Change
11.27
Today|||52-Week Range
36.61
+71.78%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Foley Mark J
Chief Executive Officer
Sale3/09/202370,390$31.59$2.2M+2.36%
Foley Mark J
Chief Executive Officer
Sale10/13/202249,274$26.97$1.3M+17.54%
Sjuts Dustin S
President
Sale3/09/202321,508$31.59$679.4K+2.36%
Schilke Tobin C
Chief Financial Officer
Sale3/09/202318,517$31.59$585.0K+2.36%
Moxie Dwight
Secretary, Senior Vice President & General Counsel
Sale3/09/202318,496$31.59$584.3K+2.36%
Moxie Dwight
Secretary, Senior Vice President & General Counsel
Sale9/14/202211,000$27.07$297.8K+15.15%
Moxie Dwight
Secretary, Senior Vice President & General Counsel
Sale3/15/20237,330$30.65$224.7K+3.43%
Foley Mark J
Chief Executive Officer
Sale3/15/20235,341$30.65$163.7K+3.43%
Schilke Tobin C
Chief Financial Officer
Sale3/15/20233,739$30.65$114.6K+3.43%
Schilke Tobin C
Chief Financial Officer
Sale3/01/20233,201$33.50$107.2K-1.71%
Page of 4